News for Relief Therapeutics Holding AG (RLFTF)

GENEVA, SWITZERLAND / ACCESS Newswire / April 10, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical compa

Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US

GENEVA, SWITZERLAND / ACCESSWIRE / December 27, 2024 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmace

Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU GOLIKE

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE

Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents

Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024

Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update

Relief Therapeutics Secures up to $11 Million from Royalty Sales

Relief Therapeutics Announces Executive Changes

Relief Therapeutics Announces  Notice of Annual General Meeting of Shareholders

Relief Therapeutics Holding AG announced it has entered into a new exclusive definitive licensing agreement with Acer Therapeutics Inc. for the development and commercialization of OLPRUVA? for the...

By Mary de Wet Acer Therapeutics Inc. has received approval from the Food and Drug Administration for Olpruva, the first of four drugs the company was investigating. The drug, also known... | December 23, 2022

Relief Therapeutics Holding AG press release (RLFTF): 1HRevenue of CHF 3.24M.Net loss for the period was CHF 26.5M, compared to a net loss of CHF 14.7M for the same period last year.

Relief Therapeutics Holding SA / Key word: Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement... | September 15, 2022

Relief Therapeutics Holding SA / Key word: Conference Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum 12.09.2022 / 07:05 CET/CEST Relief... | September 12, 2022

Read Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Short Interest Up 27.8% in May at ETF Daily News

Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Grows By 86.2% at ETF Daily News

Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Expands By 43.7% at ETF Daily News